title: Real-time myocardial blood flow imaging in normal human beings with the use of myocardial contrast echocardiography.
abstract: Triggered myocardial contrast echocardiography (MCE) has been used successfully to quantify myocardial blood flow and assess coronary stenosis in animal models, but practical considerations have limited its broad clinical use. Real-time MCE may have practical advantages to assess perfusion and real time myocardial blood flow in human beings. We compared real-time MCE with triggered imaging in 23 normal human volunteers by using an investigational ultrasound contrast agent (DMP-115) and a commercially available ultrasound platform (Acuson Sequoia). Peak myocardial opacification (reflecting myocardial blood volume) after contrast infusion was quantified digitally in gray scale units (GU). In 13 subjects, myocardial blood flow reserve was assessed during dipyridamole infusion with the use of intermittent destruction-replenishment techniques. Real-time MCE resulted in a 30- to 45-GU increase from baseline compared with a 20- to 70-GU increase with triggered imaging. Real-time MCE showed no statistical difference in opacification (P = .131 by analysis of variance) among any of the myocardial regions of interest. Triggered imaging resulted in heterogeneous opacification among the regions of interest (P < .05 by analysis of variance). Dipyridamole did not significantly change peak myocardial opacification (myocardial blood volume) for either technique. Quantification of flow reserve revealed that myocardial blood flow reserve for the dipyridamole group was 3.6 +/- 0.4 (mean +/- 1 standard error of the mean). Real-time MCE is feasible in normal human volunteers and provides homogenous opacification of the myocardium. Furthermore, quantification of myocardial blood flow with real-time MCE in normal human beings produces results that are consistent with the known physiology of the coronary microcirculation.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
authors.forename: T H
authors.initials: TH
authors.lastname: Murthy
authors.forename: P
authors.initials: P
authors.lastname: Li
authors.forename: E
authors.initials: E
authors.lastname: Locvicchio
authors.forename: C
authors.initials: C
authors.lastname: Baisch
authors.forename: I
authors.initials: I
authors.lastname: Dairywala
authors.forename: W F
authors.initials: WF
authors.lastname: Armstrong
authors.forename: M
authors.initials: M
authors.lastname: Vannan
mesh_terms: D000328:Adult; D003287:Contrast Media; D003326:Coronary Circulation; D003327:Coronary Disease; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D004176:Dipyridamole; D004452:Echocardiography / Q000009:adverse effects / Q000379:methods; D005240:Feasibility Studies; D005260:Female; D006321:Heart / Q000502:physiology; D006439:Hemodynamics; D006801:Humans; D008297:Male; D013997:Time Factors
chemical_list: D003287:Contrast Media; D004176:Dipyridamole